论文部分内容阅读
Objective: To improve the preparation of adherent lymphokine-activated killer (A-LAK) cells and study the synergistic anti-tumor effect of phenylacetate (PA) and A-LAK cells. Methods:A-LAK cells were obtained from peripheral blood mononuclear cells (PBMC)